Ticker Symbol: REGN
Regeneron Pharmaceuticals, Inc.
$642.75 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
United States
Currency:
USD
Asset
Type: Common Stock
CIK:0000872589
Company Profile
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in its laboratories. Its medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 777 Old Saw Mill River Rd
Website: www.regeneron.com
CEO: Leonard Schleifer
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $808.31
Change:
-$9.72
(
-1.19%)
Days Range: $799.77 - $816.13
Beta: 0.44
52wk. High: $853.97
52wk. Low: $668.00
Ytd. Change 12.19%
50 Day Moving Average: $828.16
200 Day Moving Average: $783.19
Shares Outstanding: 108558718
Valuation
Market Cap: 8.6T
PE Ratio: 21.38
EPS (TTM): 37.81
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A